Coral Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Coral Laboratories	Balaxi Pharma.	Alpa Lab
Operational Metrics
Financials
5 yr Average ROE	8.16 %	27.3 %	10.02 %
5yr average Equity Multiplier	1.18	1.4	1.26
5yr Average Asset Turnover Ratio	0.47	1.43	0.62
5yr Avg Net Profit Margin	14.82 %	11.03 %	13.26 %
Price to Book	0.76	0.67	0.91
P/E	9.3	10.93	8.87
5yr Avg Cash Conversion Cycle	35.5 Days	154.28 Days	114.37 Days
Inventory Days	69.25 Days	87.41 Days	51.33 Days
Days Receivable	98.13 Days	103.86 Days	142.78 Days
Days Payable	131.4 Days	63.18 Days	94.49 Days
5yr Average Interest Coverage Ratio	171.88	57.05	94.43
5yr Avg ROCE	10.48 %	36.52 %	13.16 %
5yr Avg Operating Profit Margin	14.88 %	16.64 %	7.55 %
5 yr average Debt to Equity	0.02	0.09	0.02
5yr CAGR Net Profit	12.26 %	-5.76 %	21.88 %
5yr Average Return on Assets	6.95 %	18.47 %	7.94 %
Shareholdings
Promoter Holding	71.51 %	65.99 %	57.29 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-6.87 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Coral Laboratories	Balaxi Pharma.	Alpa Lab
Product Wise Break-Up	Product Wise Break-Up Formulations 100.0 Sale of FMCG Products 0 Sale of Hardware Products 0 Sale of Pharmaceutical Products 0	Product Wise Break-Up FMCG 12.61 Formulations 0 Pharmaceutical 58.85 Hardware & Accessories Revenue 28.54	-
Location Wise Break-Up	Location Wise Break-Up Rest of the World 57.87 Ethiopia 21.5 India 19.05 Guatemala 0 Dominican Republic 0 Angola 0 Others 1.58	Location Wise Break-Up India 0 Guatemala 29.72 Ethiopia 0 Rest of the World 0 Dominican Republic 22.73 Angola 21.15 Others 26.4	-